Glenmark Life Sciences tumbled 8.16% to Rs 758.80 after the company’s declined 33.09% to Rs 97.93 core in Q4 FY24 as compared with Rs 146.35 crore in Q4 FY23.
Subscribe To Our Free Newsletter |
Glenmark Life Sciences tumbled 8.16% to Rs 758.80 after the company’s declined 33.09% to Rs 97.93 core in Q4 FY24 as compared with Rs 146.35 crore in Q4 FY23.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!